News Release

Bone specialists' hi-tech answer to patient care

Business Announcement

University of Manchester

Bone-disorder experts from across Europe have turned to the web in a unique alliance that will improve patient care.

The European Skeletal Dysplasia Network (ESDN), which was developed by The University of Manchester, links eight institutions in six different countries by means of a secure web portal.

The hi-tech referral system means a patient, say, in Italy could have their case referred to a bone specialist in Belgium and a genetics expert in Manchester, while a laboratory in Switzerland confirms the diagnosis.

The network allows a doctor to submit a description and x-ray images of their patient to the portal, which are then referred to a group of specialists connected through an electronic discussion forum who can consider the case.

"There is no one centre with all the necessary experience or facilities to cope with the diagnosis of so many types of bone disorders," said project administrator Jacky Taylor, who is based at the National Genetics Reference Laboratory in Manchester.

"There are more than 200 different kinds of complaints ranging from mild to life-threatening, so clinicians face significant problems identifying which condition their patient has.

"This web-based, case-management system overcomes geographical barriers and brings together the scarce clinical resources for these rare conditions.

"By providing efficient access to a pan-European network of experts and genetic-testing facilities, doctors can make accurate diagnoses enabling patients to receive the best treatment for their particular condition.

"The system is completely novel and the successful delivery of the complex IT project is thanks to the collaborative nature of ESDN itself."

The technology behind the system was provided by Certus Technology, a young IT company with engineering and consulting experience. Dr Mike Briggs, of the Wellcome Trust Centre For Cell Matrix Research in Manchester, heads the eight partner centres, which in the UK also include The University of Newcastle-upon-Tyne and the Central Manchester NHS Trust.

He said: "Now ESDN has a system that works, the trick is to broaden its reach. There are significant barriers to its adoption; the general uptake of IT in medicine is a problem."

Dr Michael Wright, of the Institute of Human Genetics at The University Newcastle-upon-Tyne, added: "This is a system that works the way we work. What is interesting is that because of the system, conversations about cases are taking place that otherwise wouldn't.

"The information technology is facilitating the diagnosis of patients and, significantly, is bringing together this multidisciplinary group in a way that is improving understanding."

###

For further information, contact Jacky Taylor: jacky.taylor@cmmc.nhs.uk
For more about ESDN visit: www.esdn.org
For more about Certus go to: www.certus-tech.com

Notes to editors:
ESDN comprises eight partners in six European countries:
Belgium, Finland, France, Germany, Switzerland and the UK

The eight partner centres are:

  • The Wellcome Trust Centre For Cell Matrix Research, The University of Manchester, UK (Mike Briggs)
  • The National Genetics Reference Laboratory, Manchester, UK (Rob Elles)
  • Ghent University Hospital, Ghent, Belgium (Geert Mortier)
  • The International Centre for Life, Newcastle-upon-Tyne, UK (Michael Wright and Judith Goodship)
  • Hopital Necker-Enfants Malades, Paris, France (Jacky Bonaventure)
  • The University of Oulu, Oulu, Finland (Leena Ala-Kokko)
  • Children's Hospital, University of Mainz, Mainz, Germany (Bernhard Zabel)
  • Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (Andrea Superti-Furga)

    ESDN is currently funded by the European Union and the Swiss Government (European Commission 5th FP: QLG1-CT-2001-02188; Swiss: OFES 01.0258)


  • Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.